← FDA Drug Approvals (Drugs@FDA)
LEQEMBI IQLIK
BLA · Biologics License Application · Sponsor: EISAI INC · Approved 2025-08-29
Drug application
- FDA Application #
BLA761375- Application type
- Biologics License Application
- Brand name
- LEQEMBI IQLIK
- Generic name
- LECANEMAB-IRMB
- Active ingredients
- LECANEMAB-IRMB
- Dosage form
- INJECTABLE
- Route
- SUBCUTANEOUS
- Marketing status
- Prescription
- Sponsor
- EISAI INC
- Manufacturer
- Eisai Inc.
- First approval
- 2025-08-29
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown